Warning! The directory is not yet complete and will be amended until the beginning of the term.
323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2022S)
(2 Courses)
Continuous assessment of course work
Labels
Details
Language: English
Lecturers
Classes
25 April (Monday) 9.00 - 10.00 Uhr s.t.
Case Study 1 (Nussbaumer, Lead Discovery):
-28 April 16:30 -18:30
-19 May 16:30 - 18:30
-21 June 16:30 - 18:30
Case Study 2 (Ettmayer, Boehringer Ingelheim):
-26 April 8:30 - 10:30
-12 May 8:30 - 10:30
-08 June 8:30 - 10:30
Case Study 3 (Boss & Roch, Idorsia):
-27 April 13:00 - 15:00
-13 May 14:00 - 16:00
-03 June 14:00 - 16:00
Information
Aims, contents and method of the course
Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.
Assessment and permitted materials
Students must attend all sessions and actively participate in the discussion, complete and submit all of the assignments. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal due before the last day of class.
Minimum requirements and assessment criteria
Enrollment in the Master of Drug Discovery and Development program. Successful completion of MPS1 in the Master of Drug Discovery and Development program. Course attendance; completion of assignments including revisions from feedback sessions to be submitted to instructors for evaluation. Final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors.
Examination topics
Reading list
To be given in class
Association in the course directory
Last modified: Tu 25.01.2022 13:09